OPALIN and Alzheimer disease: Together, our study in APOE E4+ carriers and two previously published studies in AD donors consistently show downregulation of oligodendrocyte differentiation and myelination genes, such as PLP1 and OPALIN, and their corresponding GO terms17,19.